Bharat Biotech begins direct supply of COVAXIN to 14 states

Bharat Biotech has commenced direct supply of its COVID-19 vaccine ‘COVAXIN’ to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director Suchitra Ella.

The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government.

“Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24×7,” Ella tweeted.

The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.

On April 29, Bharat Biotech announced a cut in the price of ‘COVAXIN’ for states to ₹400 per dose from the earlier ₹600 per dose.

This followed widespread criticism of its pricing policy as it sold COVAXIN to the central government at ₹150 per dose.